Novo Nordisk A/S
Novo Nordisk is seeking In Vivo Pharmacologists to support target validation and early pipeline development for cardiometabolic diseases. This open-rank role involves designing and executing rodent pharmacology studies, analyzing data to inform drug discovery decisions, and collaborating cross-functionally with teams in bioinformatics, PK/PD, and safety. Candidates will contribute to new drug target proposals and ensure compliance with scientific standards.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Novo Nordisk A/S didn’t post a salary, so this is our estimate from similar listings.
Veterinary Technician / Research Associate
Septerna
Preclinical PK/PD Modeler / Quantitative Pharmacology Scientist
Ridgeline Discovery GmbH
Associate Principal Scientist
Merck & Co., Inc.
Associate Scientist II/Scientist I - In Vivo Pharmacology
AbbVie
Senior Director, In Vivo Pharmacology
Generate:Biomedicines
Senior Scientist I
Exelixis